TVTX icon

Travere Therapeutics
TVTX

Overview Fund Trends Analyst Outlook Journalist POV

174 hedge funds and large institutions have $677M invested in Travere Therapeutics in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

16% less capital invested

Capital invested by funds: $807M → $677M (-$129M)

81% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $5.82M

Holders
174
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.09M
Puts
$5.82M
Net Calls
Net Calls Change

Top Buyers

1
+$9.69M
2
+$7.37M
3
+$7M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.72M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.79M

Top Sellers

1
-$36.6M
2
-$9.84M
3
-$7.43M
4
Goldman Sachs
Goldman Sachs
New York
-$5.95M
5
WP
Woodline Partners
California
-$5.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$5.54M
27
$5.4M
28
$4.59M
29
$4.28M
30
$4.16M
31
$3.91M
32
$3.89M
33
$3.85M
34
$3.4M
35
$3.21M
36
$3M
37
$2.87M
38
$2.79M
39
$2.69M
40
$2.68M
41
$2.53M
42
$1.78M
43
$1.73M
44
$1.69M
45
$1.69M
46
$1.6M
47
$1.57M
48
$1.51M
49
$1.42M
50
$1.37M
1
2
3 4 5